Lupin Limited Share Price and Company Fundamentals
Last traded: Today at 7:56 AM
Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally. The company operates in two segments: Pharmaceuticals and Others. It produces, develops, and markets various branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). The company also offers products in the therapeutic areas of cardiovascular, diabetology, asthama, pediatrics, central nervous system, gastro-intestinal, anti-infectives, anti-TB, cephalosporins, and nonsteroidal anti-inflammatory drug therapies. In addition, it provides chronic therapies, and hospital-based products; products for diabetes and iron supplements for anemia, and a Budesonide-Formoterol combination for asthma. Further, the company is involved in the provision of diagnostics services, and digital healthcare services; and neuro rehabilition business. It operates through network consisting of labs and collection centers. The company has a strategic collaboration with TB Alliance to support the clinical development and commercialization of Telacebec for the treatment of tuberculosis, leprosy, and buruli ulcer. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.
Key Metrics
PE ratio
18.38
PB ratio
4.51
Dividend yield
0.80%
Beta
0.18
Market cap
₹1013.60B
Enterprise value
₹1008.29B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 26021 |
| Website | https://www.lupin.com |
| Mailing address | Kalpataru Inspire 3rd Floor Off. Western Expressway Highway Santacruz (East) Mumbai 400055 India |
| Phone / Fax | 91 22 6640 2323 / 91 22 6640 2051 |
Dividends
Dividend yield
0.80%
Dividend amount
₹18.00
Payout ratio
9.94%
5Y Avg. yield
-%
Lupin Limited paid ₹18.00 dividend and the ex-dividend date was 17 Jul 2026.The dividend payout ratio is 9.94%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.LUPIN dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Aug 2026, following are the company executives and directors listed on Lupin Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Ms. Vinita D. Gupta | CEO & Executive Director | 57 | |
| Mr. Ramesh Swaminathan | Executive Director, Global CFO, CRO & Head of API Plus SBU and IT | 59 | |
| Mr. Nilesh Deshbandhu Gupta | MD & Executive Director | 51 | |
| Mr. Christoph Funke | Chief Technical Operations Officer | ||
| Dr. Shahin Fesharaki | Chief Scientific Officer | ||
| Mr. Ravi Agrawal | Sr. Vice President of Investor Relations and M&A | ||
| Ms. Rajalakshmi Azariah | Vice President & Global Head of Corporate Communications | ||
| Dr. Fabrice Egros M.B.A., Ph.D., Pharm.D. | President of Corporate Development | 62 | |
| Mr. Yashwant S. Mahadik B.Com, MBA | President of Global Human Resources | 58 | |
| Dr. Sofia Mumtaz | President of Legal and Compliance, Canada, ANZ, and NEA business |
Profitability and management effectiveness
Profit margin
18.45%
Operating margin
25.35%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Lupin Limited is 1013.60B and its enterprise value is 1008.29B. The enterprise value to revenue ratio of LUPIN is 3.37. The enterprise value to EBITDA ratio of LUPIN is 11.66.
The LUPIN's stocks Beta value is 0.18 making it 82% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Lupin Limited (NSE:LUPIN) Frequently Asked Questions
1. What is Lupin Limited's Stock Symbol?
Lupin Limited trades on NSE under the ticker symbol "LUPIN".
2. What is Lupin Limited's stock price today?
One share of LUPIN stock can currently be purchased for approximately ₹2216.8.
3. How can I contact Lupin Limited?
Lupin Limited's mailing address is Kalpataru Inspire 3rd Floor Off. Western Expressway Highway Santacruz (East) Mumbai 400055 India. The company can be reached via phone at 91 22 6640 2323.
4. What is Lupin Limited's official website?
The official website of Lupin Limited is https://www.lupin.com.